BGLC insider transaction filings
BioNexus Gene Lab Corp — 5 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-14. Screen BGLC transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 5 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 5.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Bin Abdul Hamid Muhammad Azrul — Director | 1 | — | — | 1 |
| Chong Set Fui — Chief Financial Officer | 1 | — | — | 1 |
| Low Jook Yuen — Director | 1 | — | — | 1 |
| Tan Lee Su-Leng — Chief Executive Officer, Director, 10% owner | 1 | — | — | 1 |
| Yap Chee Keong — Director | 1 | — | — | 1 |
Recent Form 4 filings — BioNexus Gene Lab Corp
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-14 | 4 | Tan Lee Su-Leng — Chief Executive Officer, Director, 10% owner | Grant/award (A): 338,709 | EDGAR |
| 2026-08-14 | 4 | Chong Set Fui — Chief Financial Officer | Grant/award (A): 96,774 | EDGAR |
| 2026-08-14 | 4 | Bin Abdul Hamid Muhammad Azrul — Director | Grant/award (A): 32,258 | EDGAR |
| 2026-08-14 | 4 | Yap Chee Keong — Director | Grant/award (A): 32,258 | EDGAR |
| 2026-08-14 | 4 | Low Jook Yuen — Director | Grant/award (A): 16,129 | EDGAR |
Recent 8-K events — BioNexus Gene Lab Corp
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-28 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-05 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-17 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-23 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-03 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-30 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-12-23 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-12-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-13 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-12 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BGLC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →